Core Viewpoint - AXIS Capital Holdings Limited is set to release its financial results for the first quarter of 2026 on April 29, 2026, after market close [1] Group 1: Financial Results Announcement - The financial results for the first quarter ended March 31, 2026, will be announced on April 29, 2026 [1] - The announcement will be followed by an investor teleconference on April 30, 2026, at 8:30 a.m. ET [2] Group 2: Teleconference Details - Investors can access the teleconference by dialing specific numbers for U.S., Canada, and international callers, with a passcode required [3] - A live webcast of the teleconference will be available on the company's website [3] Group 3: Replay Information - A replay of the teleconference will be available for one week, with specific dialing instructions for U.S., Canada, and international callers [4] - The webcast will also be archived on the company's website [4] Group 4: Company Overview - AXIS Capital is a global specialty underwriter and provider of insurance and reinsurance solutions, with shareholders' equity of $6.4 billion as of December 31, 2025 [5] - The company has a strong financial strength rating of "A+" from Standard & Poor's and "A" from A.M. Best [5]

Core Viewpoint - Excelerate Energy has officially named its newest floating storage and regasification unit (FSRU), Excelerate Acadia, during a ceremony at Hyundai Heavy Industries shipyard, marking a significant milestone in the company's operations and partnerships [1][2][3]. Group 1: Naming Ceremony - The naming ceremony signifies Excelerate Energy's ongoing collaboration with leading global shipbuilders, specifically marking the first FSRU constructed at HD Hyundai Heavy Industries [2]. - The event was attended by company leadership, shipyard representatives, and guests, celebrating the formal christening of the vessel [2]. - Deborah Byers, a board member of Excelerate Energy, performed the ceremonial naming, adhering to maritime traditions [3]. Group 2: Vessel Specifications and Purpose - Excelerate Acadia is designed to support long-term LNG import and regasification operations, reflecting the company's commitment to investing in purpose-built floating storage and regasification units [4]. - The vessel features a modern design with advanced efficiency and safety features, including redundant systems to ensure reliable performance [4]. Group 3: Company Overview - Excelerate Energy, Inc. is a U.S.-based LNG and power infrastructure company located in The Woodlands, Texas, focused on enhancing global energy security through reliable energy infrastructure [5]. - The company operates across various locations worldwide, providing services along the LNG to power value chain, including floating regasification terminals and power generation [5].

Core Insights - Perimeter Medical Imaging AI, Inc. reported record revenues and improved operating performance for Q4 and full year 2025, marking a pivotal year for the company with significant growth opportunities ahead [2][4]. Financial Performance - Q4 2025 revenue reached approximately $711,000, representing a 143% increase year-over-year compared to Q4 2024 and a 33% increase sequentially from Q3 2025 [4][7]. - Full year 2025 revenue totaled approximately $2.3 million, a 172% increase compared to approximately $846,000 in 2024, driven by the commercial adoption of the Perimeter S-Series OCT [8][9]. - Operating expenses for Q4 2025 were approximately $2.5 million, down 46% from $4.7 million in Q4 2024 [7]. - The net loss for Q4 2025 was approximately $2.0 million, or $0.02 per share, a 42% improvement from a net loss of approximately $3.4 million, or $0.06 per share, in Q4 2024 [8]. - Full year 2025 net loss was approximately $12.9 million, or $0.16 per share, compared to a net loss of approximately $13.4 million, or $0.19 per share, in 2024 [9]. Product Development and Market Position - The FDA granted PMA approval for the Claire OCT device in March 2026, which is expected to enhance patient outcomes in breast cancer surgery [2][3]. - Claire OCT is the first AI-enabled imaging device approved for intraoperative breast cancer margin assessment, delivering 10 times higher resolution than standard imaging methods [11][24]. - The company is preparing for the U.S. commercial launch of Claire, anticipated to begin in Q2 2026 [11]. Strategic Partnerships and Market Expansion - In November 2025, the S-Series OCT was adopted by HCA HealthONE, marking its first use in Colorado [4]. - In January 2026, Perimeter entered into an agreement with Intermountain Health for the deployment of S-Series OCT in operating rooms [4]. Corporate Updates - As of December 31, 2025, the company had approximately $2.5 million in cash [10]. - In December 2025, Perimeter closed a non-brokered private placement, raising approximately C$3.56 million [11]. - The company is focused on expanding its presence with leading healthcare institutions across the U.S. and advancing its clinical and product roadmap [2].

Core Viewpoint - Camden National Corporation has declared a quarterly dividend of $0.42 per share, resulting in an annualized dividend yield of 3.57% based on the stock's closing price of $47.03 on March 30, 2026 [1]. Group 1: Dividend Announcement - The board of directors of Camden National Corporation announced a quarterly dividend of $0.42 per share [1]. - The dividend is payable on April 30, 2026, to shareholders of record as of April 15, 2026 [1]. Group 2: Company Overview - Camden National Corporation is the largest publicly traded bank holding company in Northern New England, with total assets of $7.0 billion [2]. - The company operates 72 banking centers in Maine and New Hampshire and offers full-service community banking along with digital banking services [2].

Core Insights - Milestone Scientific Inc. is transitioning from a restructuring phase to a growth phase, with expectations for double-digit revenue growth in 2026 and a significant increase in CompuFlo sales [2][3]. Business Update - The company has implemented financial discipline since August 2025, focusing on revenue-generating initiatives and eliminating inefficient spending [2]. - A dental ambassador program was launched in December 2025, and CompuFlo commercialization efforts are being relaunched [2]. - The company is processing registrations for its STA product in Japan, India, and Mexico, while also securing new distribution partners for CompuFlo [2]. Financial Performance - For Q4 2025, total revenue was $2.1 million, a 2.2% increase from $2.0 million in Q4 2024 [4]. - The operating loss for Q4 2025 improved by 89% to $1.1 million compared to $2.0 million in the prior year [5]. - For the full year 2025, total revenue was $9.0 million, a 4% increase from $8.6 million in 2024, driven by higher international dental sales [6][7]. Future Outlook - For 2026, total revenue is expected to be between $9.8 million and $10.2 million, with CompuFlo revenue projected to increase by approximately 400% to between $500,000 and $600,000 [9]. - The company aims to achieve cash flow breakeven by early 2027, focusing on long-term shareholder value [3].

Core Insights - FibroBiologics has successfully completed the manufacturing of its proprietary CYWC628 drug product, which is set to support upcoming first-in-human clinical trials [1][3] - The CYWC628 therapy targets diabetic foot ulcers, a condition affecting millions globally with no effective long-term treatment options [2] - This marks the first large-scale CGMP manufacturing of a fibroblast-based spheroid therapeutic candidate, allowing the company to proceed with planned Phase 1/2 clinical trials in DFU patients in the first half of 2026 [3] Company Overview - FibroBiologics is a clinical-stage biotechnology company based in Houston, focusing on developing therapeutics and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials [5] - The company holds over 270 patents issued and pending, covering various clinical pathways including wound healing, multiple sclerosis, disc degeneration, psoriasis, orthopedics, human longevity, and cancer [5]

Core Viewpoint - Labcorp Holdings Inc. will announce its financial results for the first quarter of 2026 on April 30, 2026, before market opening, and will host a webcast to discuss these results [1]. Group 1: Financial Results Announcement - Labcorp will release its first quarter financial results on April 30, 2026, before the market opens [1]. - A webcast will be held at 9:00 a.m. ET on the same day to discuss the financial results [1]. - The earnings press release and financial information will be available on the Labcorp Investor Relations website [1]. Group 2: Company Overview - Labcorp is a global leader in laboratory services, aiding healthcare professionals and researchers in decision-making [3]. - The company employs nearly 71,000 individuals and serves clients in approximately 100 countries [3]. - Labcorp supported over 85% of new drugs and therapeutic products approved by the FDA in 2025 and conducted more than 750 million tests globally [3].

Core Insights - The company has improved gross margins, significantly reduced net loss, and strengthened its balance sheet, positioning itself for scalable growth in defense and commercial markets by 2026 [1][4] Corporate Highlights FY2025 - The company executed a disciplined strategy in 2025, focusing on streamlining operations and aligning costs with demand across various markets [4] - There was a deliberate shift towards higher-value opportunities, enhancing operational leverage and clarity for future growth [4][5] Financial Highlights FY2025 - Cash on hand increased to approximately $29.9 million, a rise of $26.3 million or about 730% compared to $3.6 million in 2024 [10] - Revenues for the year were $12.8 million, a decrease of $0.6 million or 4.3% from $13.4 million in 2024, attributed to a shift in revenue mix [10] - Gross profit rose to $6.6 million, an increase of $0.4 million or 5.6%, with gross margin expanding to 51.8% from 47.0% [10] - General and administrative expenses decreased by $0.6 million or 6.4% to $9.0 million, while research and development expenses fell by $0.4 million or 9.0% to $3.6 million [10] - The net loss improved to $(5.3) million, a reduction of $29.7 million or approximately 85% compared to $(35.0) million in 2024 [10] Strategic Initiatives - The company expanded its defense and government footprint through international deployments of the eBee VISION platform in Latin America and Asia [7] - A strategic investment was initiated in Aerodrome Group Ltd., enhancing exposure to next-generation unmanned systems [7] - The company launched global shipments of next-generation RedEdge-P sensors, strengthening its position in precision agriculture and advanced imaging [7] - Total aggregate proceeds of approximately $36.2 million were raised from preferred equity issuances and warrant exercises, supporting ongoing operations and strategic initiatives [7]

Group 1 - BK Technologies Corporation has announced the registration for its Vision 2030 Investor Day, which will take place on April 2, 2026, at 9:00 am ET [2][3] - The event will feature presentations from senior company leaders, including the CEO, CFO, and other key executives, focusing on the company's Vision 2030 objectives and market outlook [3] - Participants are encouraged to join the webcast 10 minutes prior to the start of the presentation, and the event will include a question-and-answer session moderated by a research director [3] Group 2 - BK Technologies specializes in manufacturing high-specification communications equipment for public safety and government agencies, with a focus on reliability and value [4] - The company's BKR 9000 multiband portable radio is designed to meet the critical demands of first responders, combining advanced features with rugged durability [4] - BK Technologies' Solutions business unit integrates land mobile radio (LMR) and LTE/5G technologies to ensure seamless connectivity for first responders during both planned and emergency events [4]

Group 1 - American Tower Corporation plans to release its first quarter 2026 earnings results on April 28, 2026, at 7:00 a.m. ET, followed by a conference call at 8:30 a.m. ET to discuss the results [1][2] - The company has declared a quarterly cash distribution of $1.79 per share, payable on April 28, 2026, to stockholders of record as of April 14, 2026 [5] - American Tower is one of the largest global REITs, owning and operating nearly 150,000 communications sites and a network of U.S. data center facilities [3][6] Group 2 - The company reported strong financial results for the fourth quarter and full year 2025, achieving high-single-digit growth in AFFO per Share, driven by robust leasing demand across its global tower portfolio and data center business [7] - American Tower is scheduled to present at the Deutsche Bank 34th Annual Media, Internet and Telecom Conference on March 9, 2026 [6]